A L Caplan

Summary

Affiliation: New York University School of Medicine
Country: USA

Publications

  1. doi request reprint Adverse event management in mass drug administration for neglected tropical diseases
    Arthur Caplan
    NYU, Langone Medical Center, New York, New York Electronic address
    Clin Ther 36:421-4. 2014
  2. doi request reprint Enhancing patient autonomy through peer review to replace the FDA's rigorous approval process
    Arthur Caplan
    Division of Bioethics, New York University Langone Medical Center, New York, NY, USA
    Health Aff (Millwood) 31:2236-40. 2012
  3. doi request reprint Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best
    A L Caplan
    Division of Medical Ethics, Langone Medical Center, New York University, New York, New York, USA
    Clin Pharmacol Ther 92:411-2. 2012

Detail Information

Publications3

  1. doi request reprint Adverse event management in mass drug administration for neglected tropical diseases
    Arthur Caplan
    NYU, Langone Medical Center, New York, New York Electronic address
    Clin Ther 36:421-4. 2014
    ..Denying beneficial research interventions and MDA programs intended to benefit millions requires sound ethical justification based on more than the identification of and rote response to AEs and SAEs. ..
  2. doi request reprint Enhancing patient autonomy through peer review to replace the FDA's rigorous approval process
    Arthur Caplan
    Division of Bioethics, New York University Langone Medical Center, New York, NY, USA
    Health Aff (Millwood) 31:2236-40. 2012
    ..The hypothetical comparative effectiveness case study in this month's Health Affairs does not appear to rise to the level that would be helpful to providers or patients...
  3. doi request reprint Without an adequate ethical infrastructure, the road to personalized medicine will be rocky at best
    A L Caplan
    Division of Medical Ethics, Langone Medical Center, New York University, New York, New York, USA
    Clin Pharmacol Ther 92:411-2. 2012
    ..There also remain significant ethical and policy obstacles that may hinder the arrival of personalized medicine. The emergence of new prenatal genetic tests make the resolution of these ethical challenges imperative...